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Abstract
Background:  Malignant transformation of intestinal endometriosis is a rare event with an
unknown rate of incidence. Metachronous progression of endometriosis to adenocarcinoma from
two distant intestinal foci happening in the same patient has not been previously reported.
Case presentation: We describe a case of metachronic transformation of ileal and rectal
endometriosis into an adenocarcinoma occurring in a 45-year-old female without macroscopic
pelvic involvement of her endometriosis. First, a right colectomy was performed due to intestinal
obstruction by an ileal mass. Pathological examination revealed an ileal endometrioid
adenocarcinoma and contiguous microscopic endometriotic foci. Twenty months later, a rectal
mass was discovered. An endoscopic biopsy revealed an adenocarcinoma. En bloc anterior rectum
resection, hysterectomy and bilateral salpingectomy were performed. A second endometrioid
adenocarcinoma arising from a focus of endometriosis within the wall of the rectum was diagnosed.
Conclusion:  Intestinal endometriosis should be considered a premalignant condition in
premenopausal women.
Background
The development of a malignancy is a relatively common
complication of endometriosis [1]. In fact, several publi-
cations have reported malignant neoplasms arising from
endometriosis. Most of these publications are case reports
or refer to a small series of patients presenting either ovar-
ian carcinomas with associated endometriosis or invasive
endometrioid adenocarcinomas involving adjacent pelvic
structures [2]. Malignant transformation of extraovarian
endometriosis, including the intestinal tract, however, has
not been reported as frequently [3]. The largest reported
series of neoplastic changes in gastrointesinal endometri-
osis includes 17 cases [4] We describe a case of meta-
chronic malignant transformation arising from two
different intestinal endometriotic sites, ileal and rectal,
occurring in the same patient.
Case presentation
A 45-year-old woman was admitted to the hospital
because of a 5 month history of paroxistic abdominal
pain and vomiting. The patient's past medical history
included ovarian endometriosis treated with bilateral
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oophorectomy in another hospital seven years earlier. She
subsequently received treatment with medroxyprogester-
one and transdermal estrogens.
On physical examination the abdomen was distended
and bowel sounds were increased. Laboratory values were
unremarkable, and abdominal x-rays confirmed the diag-
nosis of intestinal obstruction. Laparotomy revealed an
ileal mass protruding into the lumen. A right hemicolec-
tomy including 40 cm of ileum was performed. The
female genital tract and pelvis had no macroscopic evi-
dence of endometriotic lesions.
Histopathology revealed the following: the resection spec-
imen consisted of 16 cm of right colon and 39 cm of
ileum. A tumor measuring 5.5 cm was found within the
wall of the ileum 2 cm from the ileocaecal valve. Morpho-
logic and immunohistochemical features were typical of
an endometrioid adenocarcinoma (cytokeratin (CK) 7-
positive, vimentin-positive, CK20-negative) (figure 1).
The high nuclear grade tumor involved the mucosa, the
muscularis propria and the subserosal fat. Vascular inva-
sion was noted as well as metastatic involvement of 5 out
of 40 isolated lymph nodes. Several foci of endometriosis
were identified adjacent to this mass and in the caecum.
Both, the epithelial and the stromal cells tested positive
for estrogen receptors and for CK7, while tests for CK20
proved negative. The tumor itself showed only weak pos-
itivity for estrogen receptors.
After surgery the patient received subsequent chemother-
apy with 5-fluorouracil and leucovorin. Twenty months
later the patient noted rectal bleeding. A colonoscopy dis-
covered a mass at 15 cm from the anal edge. The biopsy
A. Infiltrative endometrioid adenocarcinoma of the ileum (hematoxylin-eosin stain, 100×) Figure 1
A. Infiltrative endometrioid adenocarcinoma of the ileum (hematoxylin-eosin stain, 100×). B. Cytokeratin 20 immunostaining 
negative (100×). C. Cytokeratin 7 immunostaining positive (100×). D. Cecum intraparietal benign endometriosis (hematoxylin-
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showed an adenocarcinoma. A second endometrioid ade-
nocarcinoma was not suspected before surgery.
During laparotomy a tumor in the anterior wall of the rec-
tum was seen. It was fixed to the uterus, occupying the
recto-uterine pouch which it seemed to invade. No mac-
roscopic endometrioid foci were seen in the pelvis. En
bloc resection including rectum, uterus and the fallopian
tubes was performed, as an invasion of the uterus was sus-
pected. Transit restoration was achieved by termino-ter-
minal anastomosis using the EEA-stapler device.
Histopathology revealed the following: The resection
specimen consisted of 18 cm of rectum, the uterus and the
fallopian tubes. Histological examination confirmed the
presence of a tumor measuring 3.5 cm in diameter,
located in the anterior wall of the rectum and embedded
to the posterior wall of the uterus. The poorly differenti-
ated adenocarcinoma involved all layers of the intestine
up to the uterus which was not invaded microscopically.
The uterus and the fallopian tubes had no major micro-
scopic changes. Morphological and immunohistochemi-
cal features of this endometriotic adenocarcinoma were
similar to the previously removed tumor (CK7- positive,
vimentin-positive, and CK20 negative) (figure 2). There
was no lymph node involvement in any of the 17
removed lymph nodes. Multiple microscopic foci of
endometriosis were seen, especially in the peritumoral
and peritubaric areas. Once again, immunohistochemical
features of these foci included positive estrogen receptors
and a positive result on CK7 in the epithelial and stromal
cells, and negative results for CK20. After the second oper-
ation, the patient started treatment with raltitrexed
(Tomudex®) and 5-Fluorouracil. After five years, she
remains asymptomatic and has no evidence of recurrence.
Discussion
Some studies suggest that the development of malignan-
cies may occur in up to 5.5 % of female patients with
endometriosis [1,3]. Only 21.3% of the cases arise from
extragonadal pelvic sites, and endometriosis-associated
intestinal tumors are even rarer [5]. Endometriosis affects
the intestinal tract in 15% to 37% of patients with pelvic
endometriosis, most commonly at the rectosigmoid colon
followed in frequency by the proximal colon, small intes-
tine, caecum, and appendix [4]. Malignant transformation
of primary gastrointestinal endometriosis without pelvic
involvement is uncommon, and its real incidence is
unknown [1]. It can mimic a primary gastrointestinal neo-
plasm. Most of these neoplasms are carcinomas, but sar-
comas and müllerian adenosarcomas have also been
described [3,4,6]. Petersen et al [7], in a large review of the
previously published endometrioid adenocarcinomas
arising in colorectal endometriosis, report less than 50
cases of neoplastic transformation, 22 of which were ade-
nocarcinomas. The others included sarcomas and mixed
müllerian tumors.
The progression to invasive cancer has been related with
hyperestrogenism, either of endogenous or of exogenous
origin [8]. A possible genetic background favoring the
onset of cancer has been reported in some patients with-
out hyperestrogenism and with a family history of cancer
[9]. The anatomic distribution and frequency of these can-
cers parallel the occurrence of which benign endometrio-
sis is found at various sites [4].
In order to classify a malignancy as arising from endome-
triosis, strict histopathologic criteria need to be fulfilled.
Sampson [10] first proposed these criteria in the year
1925. He suggested that the following should be fulfilled:
1) the presence of both malignant and benign endome-
trial tissue in the same organ; 2) the demonstration of
cancer arising in the tissue and not invading it from else-
where; and 3) the finding of tissue resembling endome-
trial stroma surrounding characteristic glands. Years later,
Scott [11] suggested an additional qualification to com-
plete Sampson's criteria: the demonstration of micro-
scopic benign endometriosis contiguous with the
malignant tissue. Our patient fulfilled the mentioned cri-
teria in both events. Also, both neoplasms could be con-
sidered as having developed from the same tumor, as their
immunohistochemical features were the same. Immuno-
histochemistry is extremely useful for determining the ori-
gin of adenocarcinomas. A panel of immunohistochemical
stains, including CK 7, CK 20, vimentin, and estrogen
receptors, may be used in order to differentiate the colonic
adenocarcinoma from the müllerian endometriotic aden-
ocarcinoma [12,13]. Endometrioid adenocarcinoma is
usually vimentin-positive. CK 7 is detected in different
types of carcinoma, but it is not frequent in the colonic
ones, unlike CK 20 which is characteristically from the
carcinomas of colonic origin. Both tumors from this
patient were vimentin-positive, CK7-positive, and CK20-
negative.
Although these immunohistochemical features can also
be found in ovarian cancer, we were able to rule out a pre-
vious history of malignant ovarian condition in our
patient. Seven years earlier, she underwent surgery
because of benign endometriosis, and in the surgical pro-
cedures that followed, no data of ovarian carcinomatosis
was found.
We think that this case demonstrates histological progres-
sion from endometriosis to invasive adenocarcinoma
involving, metachronically, two different segments of the
gastrointestinal tract in the same patient with more than
one years' lapse in appearance.World Journal of Surgical Oncology 2006, 4:93 http://www.wjso.com/content/4/1/93
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There is no adequate classification to grade and categorize
the extension of endometrioid adenocarcinomas of intes-
tinal origin. Classification may be more complicated
because these tumors arise from peritoneal implants and
invade organs from the outer to the inner layers. Some
authors [14] have used the FIGO staging to classify extrao-
varian carcinomas that arise from endometriosis. Never-
theless, even this classification has been questioned for
ovarian tumors arising from endometriosis [15].
For those endometrioid tumors which originate within
the wall of the intestine, we suggest using the TNM score
for intestinal tumors. Thus, as in this case, the ileal tumor
could be classified as T2N2M0 and the rectal one as
T3N0M0.
The main interest of this case is that the widespread intra-
parietal bowel wall endometriosis was discovered without
any macroscopic pelvic foci, similar to the case described
by Orlandi et al.[16]. Different hypothesis trying to
explain the appearance of endometrioid tissue at extrao-
varian sites have been developed. The most prevailing
hypothesis proposes that endometriosis results from
implantation of endometrial tissue that gains access to the
peritoneal cavity by retrograde flow during menstruation,
but most likely other factors also have an influence
(genetics, immunological factors, environment etc.).
Another theory implies the migration of the cells trough
the lymphatic system or via hematogenous spread, as
might have been the case in our patient.
Recently a new concept in the pathogenesis of endometri-
osis has been developed: the "neurologic hypothesis".
A. Rectal endometrioid adenocarcinoma with adjacent focus of endometriosis (hematoxylin-eosin stain, 20×) Figure 2
A. Rectal endometrioid adenocarcinoma with adjacent focus of endometriosis (hematoxylin-eosin stain, 20×). B. Rectal 
endometrioid adenocarcinoma (hematoxylin-eosin stain, 100×). C. Cytokeratin 20 immunostaining negative (100×). D. Cytok-
eratin 7 immunostaining positive (100×).World Journal of Surgical Oncology 2006, 4:93 http://www.wjso.com/content/4/1/93
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Possover et al [17] found that a comparison of the most
involved pelvic sites showed an absolute correlation with
the anatomical repartition of the pelvic sympathetic nerv-
ous system. On the other hand, Anaf et al [18] demon-
strated that there is a close histological relationship
between endometriotic lesions of the large bowel and the
nerves of this area. Endometrioid lesions seem to infiltrate
the large bowel wall preferentially along the nerves, even
at distance from the palpated lesion.
Endometriosis and its possible malignant changes should
be taken into account in the differential diagnosis of intes-
tinal masses in females. Also, clinical suspicion for malig-
nancy should be aroused in patients with abdominal pain
or rectal bleeding and a previous history of quiescent
endometriosis. Recognition of these lesions is important
because of the different management required by primary
gastrointestinal neoplasms and by those arising from
endometriosis. These differences may have significant
clinical implications.
Since intestinal resection can be performed safely in most
women with endometrioid bowel involvement, some
authors strongly support the use of aggressive surgical
extirpation of all visible intestinal endometriosis in
patients with advanced disease [19]. Total abdominal hys-
terectomy and bilateral salpingo-oophorectomy at the
time of bowel resection correlates with improved out-
come [20].
Controversy exists, however, over the optimal adjuvant
treatment, particularly in those patients whose disease is
completely eliminated. Radiotherapy has been given in
some cases [1,4,8,14], especially in patients with limited
pelvic involvement. Yantis et al. [4] mention that only 3
out of 17 patients underwent radiotherapy, including one
with an incomplete surgical resection. In a large series of
ovarian and extraovarian endometriosis-associated can-
cer, only 15 out of 115 patients received radiotherapy
[14].
Chemotherapy has been used more frequently, but the
value of this treatment is not yet proven [1]. Due to the
limited number of cases of malignant transformation of
extragonadal endometriosis and the lack of an adequate
classification, conclusions about the utility of chemother-
apy are only drawn from studies that also include malig-
nant ovarian endometriosis. The most used drugs for
chemotherapy in the last years have been platinum in
combination with paclitaxel [14]. After consulting with
the oncology department, our patient was treated as if
both events were a primary intestinal adenocarcinoma.
This kind of treatment is debatable, but the patient
remains asymptomatic five years after her second tumor
had been extirpated.
Globally, this condition is very rare. Thus, is it really
appropriate to speak about "premalignancy"? Should
endometriosis be considered a premalignant condition?
Considerable conflict exists in the literature regarding the
relationship between endometriosis and cancer [21].
Most likely, ovarian endometriosis "per se" should not be
considered a premalignant condition if reviewing the
available literature. But we do support the idea that this
situation is very different if we are considering endometri-
osis localized in the intestinal wall. The presented case
supports this statement.
Conclusion
This case is, to our knowledge, the first report on meta-
chronic malignant transformation of intestinal endome-
triosis from two distant intestinal foci. Intestinal
endometriosis should be considered a premalignant con-
dition.
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